|Date:||Sunday, 26 to Tuesday, 28 September 2021|
|Location:||Universität zu Köln, MTI-Hörsaalgebäude der Medizinischen Fakultät (Gebäude 44b), Joseph-Stelzmann-Straße 26, 50931 Cologne / Online|
Over the past 25 years, medicine has undergone an impressive development and the understanding of the pathogenesis of diseases at the molecular and cellular level has contributed significantly to the development of specific tools for the diagnosis, treatment or prevention of diseases.
However, in recent years it has also become clear that a direct translation of current knowledge into new therapeutic options for the treatment of human diseases is more complex than originally thought. One reason for this is that the principles of disease development and practically all pathomechanisms – with the exception of some rare monogenetic diseases – are the result of complex, often overlapping changes. In addition to genetic aberrations and predispositions, epigenetics plays an important role in the development and progression of diseases as well as diverse environmental and nutritional influences and complex interlocking pathomechanisms. Genetic and epigenetic changes influence the finely tuned intracellular and intercellular signal transduction networks of cells, tissues and organs, which together constitute the communication system of the human organism.
To highlight and discuss these important developments, the CMMC Symposium on 25 Years of Progress in Molecular Medicine: From Basic Research to Clinical Application offers a scientific program to inform about the progress in the different fields of molecular medicine and to enable an exchange with internationally renowned experts.
The symposium presents a scientific program with international leading experts for the following sessions: 1) Stem Cell Biology and Regenerative Medicine, 2) Molecular Oncology and Genomic Medicine, 3) Precision Medicine in Cancer Treatment, 4) Infectious Diseases, 5) Neuroplasticity and Neurodegeneration and 6) Metabolism and Aging.
The CMMC symposium will be organized as a hybrid meeting, where participants and speakers will either be present in person on site or, if personal participation is not possible, will be interactively involved online by live streaming and an highly interactive virtual meeting platform. The scientific program will be rounded off by a digital interactive poster presentation.
The symposium is co-sponsored by the Leopoldina.
The event is aimed at a professional audience as well as interested persons and will be held in English. There is no conference fee for attending the CMMC Symposium. Registration is requested via the following link:
Dr. Debora Grosskopf-Kroiher
Center for Molecular Medicine Cologne, Universität zu Köln
Tel: +49 (0)221 478 89536